BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 26278014)

  • 1. Predictors of intrahepatic cholangiocarcinoma in cirrhotic patients scanned by gadobenate dimeglumine-enhanced magnetic resonance imaging: diagnostic accuracy and confidence.
    Quaia E; Angileri R; Arban F; Gennari AG; Cova MA
    Clin Imaging; 2015; 39(6):1032-8. PubMed ID: 26278014
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Arterial enhancing-only nodules less than 2 cm in diameter in patients with liver cirrhosis: predictors of hepatocellular carcinoma diagnosis on gadobenate dimeglumine-enhanced MR imaging.
    Quaia E; Pizzolato R; De Paoli L; Angileri R; Ukmar M; Cova MA
    J Magn Reson Imaging; 2013 Apr; 37(4):892-902. PubMed ID: 23097278
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The value of gadobenate dimeglumine-enhanced hepatobiliary-phase MR imaging for the differentiation of scirrhous hepatocellular carcinoma and cholangiocarcinoma with or without hepatocellular carcinoma.
    Jeon TY; Kim SH; Lee WJ; Lim HK
    Abdom Imaging; 2010 Jun; 35(3):337-45. PubMed ID: 19350315
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cholangiocarcinoma in Cirrhosis: Value of Hepatocyte Specific Magnetic Resonance Imaging.
    Piscaglia F; Iavarone M; Galassi M; Vavassori S; Renzulli M; Forzenigo LV; Granito A; Salvatore V; Sangiovanni A; Golfieri R; Colombo M; Bolondi L
    Dig Dis; 2015 Oct; 33(6):735-44. PubMed ID: 26488875
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intrahepatic mass-forming cholangiocarcinoma: enhancement pattern on Gd-BOPTA-MRI with emphasis of hepatobiliary phase.
    Mamone G; Marrone G; Caruso S; Carollo V; Gentile G; Crino' F; Milazzo M; Luca A
    Abdom Imaging; 2015 Oct; 40(7):2313-22. PubMed ID: 25962708
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MR-imaging features of hepatocellular carcinoma capsule appearance in cirrhotic liver: comparison of gadoxetic acid and gadobenate dimeglumine.
    Dioguardi Burgio M; Picone D; Cabibbo G; Midiri M; Lagalla R; Brancatelli G
    Abdom Radiol (NY); 2016 Aug; 41(8):1546-54. PubMed ID: 27052455
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predictors of dysplastic nodule diagnosis in patients with liver cirrhosis on unenhanced and gadobenate dimeglumine-enhanced MRI with dynamic and hepatobiliary phase.
    Quaia E; De Paoli L; Pizzolato R; Angileri R; Pantano E; Degrassi F; Ukmar M; Cova MA
    AJR Am J Roentgenol; 2013 Mar; 200(3):553-62. PubMed ID: 23436844
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differentiating combined hepatocellular and cholangiocarcinoma from mass-forming intrahepatic cholangiocarcinoma using gadoxetic acid-enhanced MRI.
    Hwang J; Kim YK; Park MJ; Lee MH; Kim SH; Lee WJ; Rhim HC
    J Magn Reson Imaging; 2012 Oct; 36(4):881-9. PubMed ID: 22730271
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gadobenate dimeglumine-enhanced liver magnetic resonance imaging: value of hepatobiliary phase for the detection of focal liver lesions.
    Fu GL; Du Y; Zee CS; Yang HF; Li Y; Duan RG; Zeng NL; Xiao DM
    J Comput Assist Tomogr; 2012; 36(1):14-9. PubMed ID: 22261765
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Ring in the Liver.
    Xu J; Liang X; Cai X
    Am J Gastroenterol; 2021 Jan; 116(1):220-222. PubMed ID: 32868632
    [No Abstract]   [Full Text] [Related]  

  • 11. Analysis of gadobenate dimeglumine-enhanced MR findings for characterizing small (1-2-cm) hepatic nodules in patients at high risk for hepatocellular carcinoma.
    Kim TK; Lee KH; Jang HJ; Haider MA; Jacks LM; Menezes RJ; Park SH; Yazdi L; Sherman M; Khalili K
    Radiology; 2011 Jun; 259(3):730-8. PubMed ID: 21364083
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Added-value of ancillary imaging features for differentiating hepatocellular carcinoma from intrahepatic mass-forming cholangiocarcinoma on Gd-BOPTA-enhanced MRI in LI-RADS M.
    Zheng W; Huang H; She D; Xiong M; Chen X; Lin X; Cao D
    Abdom Radiol (NY); 2022 Mar; 47(3):957-968. PubMed ID: 34964069
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combined hepatocellular-cholangiocarcinoma: what the radiologist needs to know about biphenotypic liver carcinoma.
    Shetty AS; Fowler KJ; Brunt EM; Agarwal S; Narra VR; Menias CO
    Abdom Imaging; 2014 Apr; 39(2):310-22. PubMed ID: 24407728
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of increasing the flip angle during the hepatocyte phase of gadobenate dimeglumine-enhanced 1.5T MRI in cirrhotic patients with hepatocellular carcinoma.
    Lee EJ; Kim DJ; Cho ES; Kim KA
    J Magn Reson Imaging; 2016 Mar; 43(3):713-9. PubMed ID: 26290384
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Imaging features of intrahepatic cholangiocarcinoma in Gd-EOB-DTPA-enhanced MRI.
    Péporté AR; Sommer WH; Nikolaou K; Reiser MF; Zech CJ
    Eur J Radiol; 2013 Mar; 82(3):e101-6. PubMed ID: 23159401
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Applications of Dynamic Contrast-Enhanced Ultrasound in Differential Diagnosis of Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma in Non-cirrhotic Liver.
    Dong Y; Chen S; Möller K; Qiu YJ; Lu XY; Zhang Q; Dietrich CF; Wang WP
    Ultrasound Med Biol; 2023 Aug; 49(8):1780-1788. PubMed ID: 37156676
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Incorporating the hepatobiliary phase of gadobenate dimeglumine-enhanced MRI in the diagnosis of hepatocellular carcinoma: increasing the sensitivity without compromising specificity.
    Cortis K; Liotta R; Miraglia R; Caruso S; Tuzzolino F; Luca A
    Acta Radiol; 2016 Aug; 57(8):923-31. PubMed ID: 26567965
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of portal venous and delayed phases of gadolinium-enhanced magnetic resonance imaging study of cirrhotic liver for the detection of contrast washout of hypervascular hepatocellular carcinoma.
    Cereser L; Furlan A; Bagatto D; Girometti R; Como G; Avellini C; Orsaria M; Zuiani C; Bazzocchi M
    J Comput Assist Tomogr; 2010; 34(5):706-11. PubMed ID: 20861773
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MR imaging of intrahepatic cholangiocarcinoma with pathologic correlation.
    Maetani Y; Itoh K; Watanabe C; Shibata T; Ametani F; Yamabe H; Konishi J
    AJR Am J Roentgenol; 2001 Jun; 176(6):1499-507. PubMed ID: 11373220
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MR comparative study of combined hepatocellular-cholangiocarcinoma in normal, fibrotic, and cirrhotic livers.
    Sheng RF; Xie YH; Ji Y; Chen CZ; Yang L; Jin KP; Zeng MS
    Abdom Radiol (NY); 2016 Nov; 41(11):2102-2114. PubMed ID: 27315077
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.